NSE IPO - Apply Online, Check Issue Date, Price, Lot Size & Allotment Status

Apply for NSE IPO:

Skip to main content

Live Anavex Life Sciences Share Price Chart

O H L

Anavex Life Sciences Performance Overview

Days Range
$2.41Low
$2.44High

Markets Today

Previous Close$2.41
Open$2.42
Volume201,356
Day's Range$2.41 - $2.44
52W Range$2.25 - $10.38
Market Cap$218.76 M

Historical Performance

1M Returns-24.69
3M Returns-11.72
6M Returns-43.43
1Y Returns-72.20
5Y Returns-86.33
10Y Returns-7.31

Anavex Life Sciences Fundamentals

Market Cap$218.76 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$0.00
ROE TTM-0.43
EPS TTM$-0.15
Quarterly Earnings Growth YOYN/A
PB Ratio1.95
EBITDA$-51.41 M
Profit MarginN/A
Market Cap$218.76 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$0.00
ROE TTM-0.43
EPS TTM$-0.15
Quarterly Earnings Growth YOYN/A
PB Ratio1.95
EBITDA$-51.41 M
Profit MarginN/A

Anavex Life Sciences Profit & Loss

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Total Revenue +$0$0$0$0$0$0
Gross Profit +$0$0$0$0$0$0
Operating Income -$12.51 M-$14.46 M-$10.84 M-$6.78 M-$6.48 M$6.74 M
EBITDA -$12.51 M-$14.46 M-$10.84 M-$6.78 M-$6.48 M$6.74 M
Interest Expense $0$0$999.00 K$1.08 M$0$0
Depreciation $0$0$0$0$0$0
Income Before Tax -$11.20 M-$13.24 M-$9.83 M-$5.66 M-$5.34 M$7.82 M
Income Tax Expense $0$0$0$18.00 K$0$0
Net Income +-$11.20 M-$13.24 M-$9.83 M-$5.68 M-$5.34 M$7.82 M
Net Profit Margin ------

Anavex Life Sciences Financials Balance Sheet In USD

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Share Capital $85.00 K$85.00 K$87.00 K$93.00 K$93.00 K$93.00 K
Reserve & Surplus -$359.38 M-$372.62 M-$382.45 M-$388.13 M-$393.47 M-$385.64 M
Non-Current Liabilities $0$0$805.00 K$805.00 K$805.00 K$0
Current Liabilities $17.38 M$11.47 M$8.14 M$5.57 M$6.25 M$7.69 M
Total Liabilities $17.38 M$11.47 M$8.95 M$6.37 M$7.06 M$7.69 M
Fixed Assets $0$0$0$0$0$0
Current Assets $117.14 M$102.43 M$103.81 M$132.99 M$128.77 M$120.14 M
Total Assets $117.14 M$102.43 M$103.81 M$132.99 M$128.77 M$120.14 M

Anavex Life Sciences Cash Flow

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Net Income -$11.20 M-$13.24 M-$9.83 M-$5.68 M-$5.34 M$7.82 M
Operating Cash Flow -$5.86 M-$12.46 M-$8.60 M-$7.15 M-$4.44 M-$9.10 M
Investing Cash Flow $0$0$0$0$0$0
Financing Cash Flow $852.00 K-$2.14 M$10.02 M$36.32 M$113.00 K$0
Change in Cash -$5.00 M-$14.61 M$1.41 M$29.17 M-$4.33 M-$9.10 M

Anavex Life Sciences Return Calculator

The Anavex Life Sciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Returns Estimator

Based on past performance of this fund

ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$1,373
Invested Amount$10,000
Est. Returns$-8,627
Invest in USA Stock Today

About Anavex Life Sciences

Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.

FAQs

Anavex Life Sciences (AVXL) share price as of September 18, 2026 is $2.42. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the Anavex Life Sciences (AVXL) Share by opening an international trading account with Angel One.
Purchasing Anavex Life Sciences (AVXL) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Anavex Life Sciences (AVXL) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of Anavex Life Sciences (AVXL) or any other US company shares in Angel One for any dollar amount.
The market capitalization of Anavex Life Sciences on September 18, 2026, is $218.76 M.
Anavex Life Sciences operates in the Healthcare sector, specifically in the Healthcare industry.
In order to invest in Anavex Life Sciences (AVXL) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.

Diversify Your Portfolio with US Stocks

Invest in Wall Street Giants from India

+91
Top US Stocks

VIEW ALL

Open Free Demat Account!

Join our 3.8 Cr+ happy customers
+91